Breast cancer screening methods aimed at "early detection", whether they are orthodox tests such as mammography or alternative modalities such as thermography, have been marketed as procedures of "preventive medicine", allegedly helping to decrease mortality from breast cancer. But is this really true?
A groundbreaking new study published in the British Medical Journal reveals regular mammogram screenings do not reduce breast cancer death rates – the only true measure of whether they benefit women who undergo them.
According to a recent study, over the past 30 years in United States resulted in 1.3 million women being diagnosed with early stage breast cancer that technically never had a harmful type of cancer
You may have heard of the latest mammogram study published in the BMJ, which found no reduction in the breast cancer specific mortality in those who undergo these screenings. Why did it cause such a backlash?
For over a decade, GreenMedInfo has championed the classification of ductal carcinoma in situ (DCIS) as something other than cancer, standing firm against the tide of overdiagnosis and overtreatment.
